Keywords: liposome, company, ards, drug, fails, ph, iii

Liposome Company's ARDS Drug Fails At Ph III

Article | 08 July 1997

The Liposome Company has disclosed that its product for the treatment ofacute respiratory distress syndrome, Ventus (liposomal prostaglandin E1 for ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Pfizer

Go to company listing

Related Drugs

Abelcet

Amphotericin B

Amino Acids

Injection

Physostigmine Salicylate

Go to drug listing